All posts by: Michael Zand

About Michael Zand

Immunotherapy Plus RT for Metastatic Cancer: ‘Step Forward’ – Medscape

Continue reading

2017-09-25 NEWS

Medscape

Immunotherapy Plus RT for Metastatic Cancer: ‘Step Forward’
Medscape
SAN DIEGO, California ― Among heavily pretreated cancer patients with solid tumors and metastases to either the lung or liver, the novel combination of the immunotherapy ipilimumab (Yervoy, Bristol-Myers Squibb) and radiation therapy provided rates of …
Radiation+immunotherapy can slow tumor growth for some patients with metastatic NSCLCMedical Xpress
Immune response prognostic for prostate cancer survival, recurrence and response to radiation therapyMarkets Insider
Addition of radiation therapy to chemotherapy extends PFS in advanced non-small cell lung cancerHealio
DOTmed.com –MedPage Today
all 22 news articles »
Continue reading

2017-09-25 NEWS

Medical Xpress

Prostaglandin E1 inhibits leukemia stem cells
Medical Xpress
One reason for this, explains Hai-Hui (Howard) Xue, MD, PhD, UI professor of microbiology and immunology, is that there are two kinds of tumor cells—bulk leukemia cells that can be killed by TKI drugs, and a subset of cells called leukemia stem cells

and more »

Continue reading

2017-09-25 NEWS

Fast Company

Is CRISPR the favorite to win this year’s Nobel Prize? Maybe
Fast Company
CRISPR (that’s short for clustered regularly interspaced short palindromic repeats) is the coolest gene-editing technique around, and it is revolutionizing the field of biochemistry by making it faster, easier, cheaper, and more precise to delete

Continue reading

2017-09-25 NEWS

Is CRISPR the favorite to win this year’s Nobel Prize? Maybe
Fast Company
CRISPR (that’s short for clustered regularly interspaced short palindromic repeats) is the coolest gene-editing technique around, and it is revolutionizing the field of biochemistry by making it faster, easier, cheaper, and more precise to delete

Continue reading

2017-09-25 NEWS

Spark recruits gene therapy expert Mingozzi as new CSO; Fusion brings venture round to $46M; China OKs Gilead’s …
Endpoints News
Spark Therapeutics $ONCE has recruited Federico Mingozzi, a noted gene therapy expert at INSERM and Genethon in France, as chief scientific officer. Mingozzi picked up his PhD at the University of Ferrara, Italy and an MBA from Drexel University in …